Background Sputum-based diagnostic methods for pulmonary tuberculosis (PTB) are challenging for patients who cannot produce sputum. Non-sputum-based approaches, such as tongue swab (TS), can address this gap. This study conducts an early Health Technology Assessment (HTA) of TS for PTB diagnosi

EXECUTIVE SUMMARY This annual report has been prepared to compile and summarise the activities of the Health Intervention and Technology Assessment Program (HITAP) projects in the past year (2023). It highlights various initiatives aligned with HITAP’s vision, mission, and strategic pillars, guid

Digital health interventions (DHIs), such as electronic decision support tools, telemonitoring, or mobile health (mHealth) apps, have the potential to address health system challenges that limit the achievement of universal health coverage (UHC). Regional economic development and a growing ageing

Executive Summary Digital health in Korea encompasses a wide range of technologies and services yet lacks a clear legal definition. The Korea Institute for Industrial Economics & Trade (KIET) classifies digital health into hardware, software, and service categories, reflecting the diverse lan

The focus of HTA in this project is HTA for benefit package design. The main output will be a step-by-step guide for HTA methods and/or process guideline development, starting from key considerations in the initial phase to support the set-up of a conducive environment for good HTA, steps to follow

In Thailand, the prevalence of chronic kidney disease (CKD) is 17.5% of the population (Ingsathit et al., 2010). According to Thailand’s National Health Security Office (2021), in each year, this public health agency spends approximately 10,000 million Baht in renal dialysis and 1,000 million Baht f

The use of off-label medicines is an unexplored area for healthcare priority setting, though it is common practice in countries and can have a significant positive or negative effect on health outcomes and the efficiency of health care systems. It is therefore important to have a rational an

It is vital to have evidence-informed clinical practice guidelines or clinical indications to guide the usage of high-cost drugs in the benefits package under the Indonesian universal health coverage (JKN), managed by BPJS Kesehatan. A transparent and legit mechanism is required to support and mo